Stocks and InvestingStocks and Investing
Mon, October 25, 2021
Sun, October 24, 2021
Fri, October 22, 2021
Thu, October 21, 2021

Danielle Antalffy Maintained (ABT) at Hold with Increased Target to $140 on, Oct 21st, 2021


Published on 2024-10-27 18:15:22 - WOPRAI, Danielle Antalffy
  Print publication without navigation


Danielle Antalffy of SVB Leerink, Maintained "Abbott Laboratories" (ABT) at Hold with Increased Target from $128 to $140 on, Oct 21st, 2021.

Danielle has made no other calls on ABT in the last 4 months.



There are 7 other peers that have a rating on ABT. Out of the 7 peers that are also analyzing ABT, 1 agrees with Danielle's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Simon Baker of "Redburn Partners" Initiated at Hold on, Thursday, October 14th, 2021


These are the ratings of the 6 analyists that currently disagree with Danielle


  • Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $143 on, Wednesday, October 20th, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy and Held Target at $135 on, Sunday, October 10th, 2021
  • Joshua Jennings of "TD Cowen" Maintained at Buy and Held Target at $140 on, Friday, October 8th, 2021
  • Bob Hopkins of "B of A Securities" Maintained at Strong Buy and Held Target at $133 on, Tuesday, August 31st, 2021
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $130 on, Friday, July 23rd, 2021
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Thursday, July 22nd, 2021